Clinical Study
Clinicopathological Characteristics and Her-2/neu Status in Chinese Patients with Uterine Papillary Serous Carcinoma
Table 1
Clinicopathological features by Her-2/neu IHC status.
| | Clinicopathological features by Her-2 IHC status | | positive () | negative () | value |
| | Age (years) | | | | | āMedian (range) | 64 (58ā77) | 61 (45ā81) | .22 | | Stage | | | .03 | | āIII | 2 (15.4%) | 12 (52.2%) | | | āIIIIV | 11 (84.6%) | 11 (47.8%) | | | Myometrial invasion | | | .78 | | ā1/2 | 5 (38.5%) | 10 (43.5%) | | | āā©¾1/2 | 8 (61.5%) | 13 (56.5%) | | | Histology | | | .33 | | āPure | 9 (69.2%) | 12 (52.2%) | | | āMixed | 4 (30.8%) | 11 (47.8%) | | | LVSI | | | .4 | | āAbsent | 7 (53.8%) | 9 (39.1%) | | | āPresent | 6 (46.2%) | 14 (60.9%) | | | Grade | | | .45 | | āII | 3 (23.1%) | 3 (13.0%) | | | āIII | 10 (76.9%) | 20 (87.0%) | | | p53 | | | .08 | | āAbsent | 1 (7.7%) | 8 (34.8%) | | | āPresent | 12 (92.3%) | 15 (65.2%) | | | ER | | | .69 | | āAbsent | 10 (76.9%) | 16 (69.6%) | | | āPresent | 3 (23.1%) | 7 (30.4%) | | | PR | | | .66 | | āAbsent | 11 (84.6%) | 18 (78.3%) | | | āPresent | 2 (15.4%) | 5 (21.7%) | |
|
|
